Design of the cardiac insufficiency bisoprolol study II (CIBIS II)

Fundamental and Clinical Pharmacology

Volumn 11, Issue 2, 1997, Pages 138-142

  Lechat, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

bisoprolol; chronic heart failure; long term mortality

Indexed keywords

BETA ADRENERGIC RECEPTOR; BISOPROLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 8044222734     PISSN: 07673981     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1472-8206.1997.tb00181.x     Document Type: Article

References (24)

1. Aldermann J, Grossmann W. Are β-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy? Circulation 1985;71:854-7
2. Australian-New Zealand Heart Failure Research Collaborative Group. Effects of carvedilol, a vasodilator β-blocker, in patients with congestive heart failure due to ischemic heart disease. Circulation 1995;92:212-8
3. Bethge H, Leopold G, Wagner G. Bisoprolol in angina pectoris. Cardiovasc Drug Rev 1991;9:110-22
4. Bristow MR, Port JD, Sandoval AB, Rasmussen R, Ginsburg R, Feldmann AM. β-adrenergic receptor pathways in the failing human heart. Heart Failure 1989;5:77-90
5. Chadda K, Goldstein S, Byington R, Curb JD. Effect of propranolol after acute myocardial infarction in patients with congestive heart failure. Circulation 1986;73:503-10
6. Cheng TO. Congestive heart failure in coronary artery disease. Am J Med 1991;91:409-15
7. CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). Circulation 1994;90:1765-73
8. Consensus Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. N Engl J Med 1987; 316:1429-35
9. Currie PJ, Kelly MJ, McKenzie A et al. Oral beta-adrenergic blockade with metoprolol in chronic severe dilated cardiomyopathy. J Am Coll Cardiol 1984;3:203-9
10. Eriksson H. Heart failure: a growing public health problem. J Intern Med 1995;237:135-41
11. Fisher ML, Gottlieb SS, Plotnick GD et al. Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. J Am Coll Cardiol 1994; 23:943-50
12. Fowler MB, Bristow MR. Rationale for beta-adrenergic blocking drugs in cardiomyopathy. Am J Cardiol 1985;55(suppl D): 120D-4D
13. 2-adrenoceptors in human atrial myocardium. Circ Res 1990;66:1610-23
14. Heilbrunn SM, Shah P, Bristow MR, Valentine HA, Ginsberg R, Fowler MB. Increased β-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy. Circulation 1989;79:483-90
15. Konstam M, Dracup K, Baker D et al. Heart failure: evaluation and care of patients with left ventricular systolic dysfunction. Clinical practice guideline no 11 AHCPR Publication No 94-0612 Rockville, MD; Agency for Health Care Policy and Research, Public Health Service, US Department of Health and Human Service, June 1994
16. Lechat P. β-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) projects. J Cardiovasc Pharmacol 1990;16:158-63
17. Matthew RW, Bolli P, Prichard BNC, Weber MA. Bisoprolol. In: Messerli FH, ed. Cardiovascular Drug Therapy. 2nd edn. Philadelphia: WB Saunders Company, 1996:557-68
18. Packer M, Bristow MR, Cohn JN et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;334:1349-55
19. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991;325:293-302
20. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade. Lancet 1979;1:1374-6
21. The BEST steering committee design of the beta-blocker evaluation survival trial (BEST). Am J Cardiol 1995;75:1220-3
22. Waagstein F, Bristow MR, Swedberg K et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6
23. Waagstein F, Caidhal K, Wallentin I, Bergh C, Hjalmarson A. Long term β-blockade in dilated cardiomyopathy. Effects of short and longterm metoprolol treatment followed by with-drawal and readministration of metoprolol. Circulation 1989;80:551-63
24. Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I. Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975;37:1022-36